Optimising Lung Surfactant Protein Production In The IUGR Fetus At Risk Of Preterm Delivery
Funder
National Health and Medical Research Council
Funding Amount
$463,853.00
Summary
Pregnant women at risk of preterm labour after 24 weeks gestation are increasingly administered glucocorticoids in Australian hospitals in order to promote fetal lung maturation and a successful transition to extrauterine life. Antenatal glucocorticoid treatment reduces overall neonatal mortality, the risk of respiratory distress syndrome and the need for respiratory support. Babies that are born small may not benefit from this treatment in the same way that average size babies benefit.
Regulation Of The Placental Renin-angiotensin System By MicroRNAs; Implications For Pregnancies Complicated By Placental Insufficiency?
Funder
National Health and Medical Research Council
Funding Amount
$483,058.00
Summary
Intrauterine growth restriction (IUGR) and preeclampsia (PrE) are life threatening to mother and baby, making the baby susceptible to disease as an adult. One of the major causes of PreE and IUGR is placentation. Placentation is affected by the placental renin-angiotensin system (RAS), which is controlled by microRNAs. We will describe these microRNAs, what controls them; determine their expression and RAS expression in normal pregnancy, IUGR and PrE, thus providing novel biomarkers for their ea ....Intrauterine growth restriction (IUGR) and preeclampsia (PrE) are life threatening to mother and baby, making the baby susceptible to disease as an adult. One of the major causes of PreE and IUGR is placentation. Placentation is affected by the placental renin-angiotensin system (RAS), which is controlled by microRNAs. We will describe these microRNAs, what controls them; determine their expression and RAS expression in normal pregnancy, IUGR and PrE, thus providing novel biomarkers for their early detection.Read moreRead less
While it is clear that carrying excess body weight can jeopardize your health, and that losing excess weight is good for you, attaining and maintaining a healthy body weight remains an elusive goal for more than 60 % of Australian adults. There are many barriers that make permanent weight loss difficult. One of the main biological barriers to weight loss is that humans aren t designed to diet. Instead, we vehemently conserve body fat whenever food is scarce. This leads to a Famine Reaction that ....While it is clear that carrying excess body weight can jeopardize your health, and that losing excess weight is good for you, attaining and maintaining a healthy body weight remains an elusive goal for more than 60 % of Australian adults. There are many barriers that make permanent weight loss difficult. One of the main biological barriers to weight loss is that humans aren t designed to diet. Instead, we vehemently conserve body fat whenever food is scarce. This leads to a Famine Reaction that contributes to nagging hunger, lethargy, loss of libido, reduced metabolic rate, plateaus, and rebound weight gain in response to weight loss programs of any kind. In a new 3-year project funded by the National Health and Medical Research Council of Australia, molecular scientists Dr Amanda Sainsbury-Salis and Associate Professor Herbert Herzog from the Garvan Institute endeavor to get to the root of the problem. Using cutting-edge molecular, genetic, and metabolic technology, Sainsbury-Salis and Herzog aim to identify the main culprits for the Famine Reaction. They hypothesize that the natural brain molecules neuropeptide Y and the endogenous morphine-like peptide dynorphin act together as major instigators of the Famine Reaction. Therefore they will determine whether mice that are deficient in these molecules can lose more weight in response to dietary restriction than normal mice. Moreover, they will determine whether dual deficiency of neuropeptide Y and dynorphin can not only reduce the voracious appetite that occurs during caloric restriction (eg: dieting), but whether it can also speed up metabolism and promote the loss of body fat. If their hypothesis proves correct, then it s likely that novel pharmaceutical agents that block the effects of neuropeptide Y and dynorphin could dramatically increase the do-ability and long-term effectiveness of lifestyle changes for permanent weight loss.Read moreRead less